Literature DB >> 23404404

Discussion of modifying stage IV gastric cancer based on Borrmann classification.

Bin Yang1, Guoqiang Wu, Xiaochen Wang, Xuefeng Zhang.   

Abstract

This study aims to investigate the prognostic significance of reclassification of stage IV gastric cancers in conjunction with Borrmann type. A total of 1,673 gastric cancer patients who received a gastrectomy between 1980 and 2003 were retrospectively evaluated. Of the patients, 244 (14.58 %), 344 (20.56 %), 589 (35.21 %), and 496 (29.65 %) had stage I, II, III, and IV cancers, respectively. After Cox regression analysis, Borrmann type was identified to be the independent prognostic factor in stage IV gastric cancer. The disease-specific postoperative survival of patients with Borrmann I, II, and III tumors was clearly distinguished by TNM classification system (P<0.05), while it failed to classify Borrmann IV tumors (P=0.147). Interestingly, the disease-specific postoperative survival of stage IV patients with Borrmann IV tumors (group 1) was significantly poor than the cases with stage IV but not Borrmann IV tumors (group 2), as well as the patients with Borrmann IV while not included in stage IV tumors (group 3) (P=0.022 and P=0.000, respectively). Meanwhile, the disease-specific postoperative survival was not observed as significantly different between group 2 and group 3 (P=0.063); furthermore, group 2+3 had a better prognosis than group 1 (introduced stage IVa vs. stage IVb; P=0.006). Reclassification of stage IV through combining the present TNM classification system with Borrmann type may more accurately predict the prognosis of patients.

Entities:  

Mesh:

Year:  2013        PMID: 23404404     DOI: 10.1007/s13277-013-0673-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  23 in total

1.  Preoperative chemoradiotherapy shows promise in gastric cancer.

Authors:  Heather Lindsey
Journal:  Lancet Oncol       Date:  2004-09       Impact factor: 41.316

2.  Prognostic influence of sub-stages according to pTNM categories in patients with stage IV gastric cancer.

Authors:  Chen Li; Min Yan; Jun Chen; Min Xiang; Zheng Gang Zhu; Yan Zheng Lin
Journal:  J Surg Oncol       Date:  2009-05-01       Impact factor: 3.454

Review 3.  Modern treatment of early gastric cancer: review of the Japanese experience.

Authors:  Yosuke Adachi; Norio Shiraishi; Seigo Kitano
Journal:  Dig Surg       Date:  2002       Impact factor: 2.588

4.  Japanese Classification of Gastric Carcinoma - 2nd English Edition -

Authors: 
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

5.  Clinicopathological features of patients with Borrmann type IV gastric carcinoma.

Authors:  Dong Yi Kim; Hyeong Rok Kim; Young Jin Kim; ShinKon Kim
Journal:  ANZ J Surg       Date:  2002-10       Impact factor: 1.872

6.  Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114).

Authors:  Gary K Schwartz; Kathryn Winter; Bruce D Minsky; Christopher Crane; P John Thomson; Pramila Anne; Howard Gross; Christopher Willett; David Kelsen
Journal:  J Clin Oncol       Date:  2009-03-09       Impact factor: 44.544

7.  Comparative effect of lymph node metastasis classified by the anatomical site or by the number of nodes involved on prognosis of patients with gastric cancer.

Authors:  Hideki Hidaka; Tadaaki Eto; Naoki Maehara; Seiichiro Jimi; Masayuki Hotokezaka; Kazuo Chijiiwa
Journal:  Hepatogastroenterology       Date:  2008 Nov-Dec

8.  Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM.

Authors:  Ji Yeong An; Tae Kyung Ha; Jae Hyung Noh; Tae Sung Sohn; Sung Kim
Journal:  Arch Surg       Date:  2009-01

9.  Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.

Authors:  Chin-Yau Chen; Chew-Wen Wu; Su-Shun Lo; Mao-Chin Hsieh; Wing-Yiu Lui; King-Han Shen
Journal:  Hepatogastroenterology       Date:  2002 May-Jun

10.  Impact of psychotherapeutic support for patients with gastrointestinal cancer undergoing surgery: 10-year survival results of a randomized trial.

Authors:  Thomas Küchler; Beate Bestmann; Stefanie Rappat; Doris Henne-Bruns; Sharon Wood-Dauphinee
Journal:  J Clin Oncol       Date:  2007-07-01       Impact factor: 44.544

View more
  4 in total

1.  Correlation of Primary Tumor FDG Uptake with Histopathologic Features of Advanced Gastric Cancer.

Authors:  Hae Won Kim; Kyoung Sook Won; Bong-Il Song; Yu Na Kang
Journal:  Nucl Med Mol Imaging       Date:  2015-02-25

2.  The difference in clinic-pathological features between signet ring cell carcinoma and gastric mucinous adenocarcinoma.

Authors:  Hao Jiang; Hongfeng Zhang; Lantian Tian; Xi Zhang; Yingwei Xue
Journal:  Tumour Biol       Date:  2013-05-01

3.  Retrospective evaluation of lymphatic and blood vessel invasion and Borrmann types in advanced proximal gastric cancer.

Authors:  Shan Gao; Guo-Hui Cao; Peng Ding; Yang-Yang Zhao; Peng Deng; Bin Hou; Kai Li; Xiao-Fang Liu
Journal:  World J Gastrointest Oncol       Date:  2019-08-15

4.  Pri-let-7a-1 rs10739971 polymorphism is associated with gastric cancer prognosis and might affect mature let-7a expression.

Authors:  Ying Li; Qian Xu; Jingwei Liu; Caiyun He; Quan Yuan; Chengzhong Xing; Yuan Yuan
Journal:  Onco Targets Ther       Date:  2016-07-04       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.